More importantly, we found that several members of this gene combination (CA4, SORD) are closely related to tumor metabolic reprogramming, suggesting that exosomes could influence nutrient sensing and drug response of tumor cells by regulating the cystine-methionine metabolic axis, a finding that provides a theoretical basis for the development of metabolism-intervention-based combination therapy strategies. Here, CA4 is linked to neoplasm.